Katherine Roe, CEO at Wentworth Resources talks through the Ruvuma gas development in Tanzania. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share Price (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,677.00
Bid: 1,676.50
Ask: 1,678.50
Change: 11.00 (0.66%)
Spread: 2.00 (0.12%)
Open: 1,675.00
High: 1,681.00
Low: 1,664.00
Prev. Close: 1,666.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Hikma Pharmaceuticals Plc Ord Shs 10P

Hikma Pharmaceuticals is listed in the FTSE All-Share, FTSE 350 Low Yield, FTSE 350, FTSE 100 indices.

Hikma Pharmaceuticals is part of the Medicine and Biotech sector.

Hikma Pharmaceuticals Plc Ord Shs 10P is listed on the London Stock Exchange, trading with ticker code HIK. It has a market capitalisation of £3,691m, with approximately 220m shares in issue. Over the last year, Hikma Pharmaceuticals share price has been traded in a range of 1243.5, hitting a high of 2703, and a low of 1459.5.
Hikma Pharmaceuticals Share Price
Price 1,677.00
Bid 1,676.50
Ask 1,678.50
Change 11.00 (0.66%)
Volume 71,614
Open 1,675.00
High 1,681.00
Low 1,664.00
Prev. Close 1,666.00
Currency GBX
Currency GBX
Issue Country GB
Shares in Issue 220m
Market Capitalisation £3,691m
Market Size 1,000
52 Week High 2,703.00
52 Week High Date 03-Aug-2021
52 Week Low 1,459.50
52 Week Low Date 22-Jun-2022
# Trades 408
Vol. Sold 40,895
Sold Value £683,430.60
Vol. Bought 29,323
Bought Value £490,568.76
PE Ratio 12.416
Earnings 135.067
Dividend 37.704
Yield 2.248%
Great for
Larger investment pots
Capital at risk.
Go to site
Great for
Wide range of investments
Capital at risk.
Go to site
Great for
Low Cost
Capital at risk.
Go to site

Recent Share Trades for Hikma Pharmaceuticals (HIK)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
28-Jun-2209:01:321,680.5053Sell*1,680.001,681.50890.67A Automatic Execution
28-Jun-2209:01:321,680.50124Sell*1,680.001,681.502,084A Automatic Execution
28-Jun-2209:01:321,681.00184Sell*1,680.001,681.503,093O Ordinary
28-Jun-2209:01:321,680.50197Sell*1,680.001,681.503,311A Automatic Execution
28-Jun-2209:01:321,680.50183Sell*1,680.001,681.503,075O Ordinary
28-Jun-2209:01:321,681.50115Buy*1,680.501,681.501,934A Automatic Execution
28-Jun-2209:01:321,681.50139Buy*1,680.501,681.502,337A Automatic Execution
28-Jun-2209:01:321,681.5076Buy*1,680.501,682.001,278A Automatic Execution
28-Jun-2209:01:321,681.5082Buy*1,680.001,681.501,379A Automatic Execution
28-Jun-2209:01:321,681.50197Buy*1,680.001,681.503,313A Automatic Execution

Directors Deals for Hikma Pharmaceuticals (HIK)

Announced Traded Action Notifier Price Currency Amount Holding
15-Mar-2214-Mar-22Transfer From Mazen Darwazah held the position of Executive Vice Chairman at the time of this trade. Mazen Darwazah0.0026,5142,350,275
15-Mar-2214-Mar-22Sell Sigurdur Olafsson held the position of CEO at the time of this trade. Sigurdur Olafsson1,988.00GBX27,49817,004
15-Mar-2214-Mar-22Transfer From Sigurdur Olafsson held the position of CEO at the time of this trade. Sigurdur Olafsson0.0044,50217,004
15-Mar-2214-Mar-22Sell Sigurdur Olafsson held the position of CEO at the time of this trade. Sigurdur Olafsson1,988.00GBX16,29917,004
15-Mar-2214-Mar-22Transfer From Sigurdur Olafsson held the position of CEO at the time of this trade. Sigurdur Olafsson0.0026,37717,004
Hikma Pharmaceuticals

We make quality medicines and make them accessible to the people that need them.

Hikma Pharmaceuticals Home Page

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.